Raymond James Financial’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.78M Buy
157,321
+52,809
+51% +$517K ﹤0.01% 3573
2026
Q1
$659K Sell
104,512
-65,353
-38% -$589K ﹤0.01% 4153
2025
Q4
$1.82M Buy
169,865
+16,827
+11% +$185K ﹤0.01% 3350
2025
Q3
$1.91M Sell
153,038
-7,595
-5% -$77.8K ﹤0.01% 3209
2025
Q2
$1.64M Buy
160,633
+4,653
+3% +$41K ﹤0.01% 3243
2025
Q1
$1.23M Sell
155,980
-157,717
-50% -$1.94M ﹤0.01% 3333
2024
Q4
$2.46M Buy
+313,697
New +$1.57M ﹤0.01% 2820

Other funds holding CRNC

Raymond James Financial's CRNC Position: Q2 2026 in Review

Raymond James Financial increased its Cerence (CRNC) stake by 51% in Q2 2026, buying an estimated $517K and bringing the position to 157,321 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #3573.

Raymond James Financial first reported a position in CRNC in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.46M in Q4 2024. 196 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • Raymond James Financial held 157,321 shares of Cerence worth $1.78M as of Q2 2026.
  • Raymond James Financial bought 52,809 Cerence shares in Q2 2026, an estimated $517K.
  • Cerence made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3573 holding.
  • Raymond James Financial first reported a position in Cerence in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Cerence position peaked at $2.46M in Q4 2024.
  • 196 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.